Mary V Relling Selected Research

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

1/2022	Dasatinib does not exacerbate dexamethasone-induced osteonecrosis in murine models of acute lymphoblastic leukemia therapy.
1/2022	Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia.
1/2022	Comprehensive characterization of pharmacogenetic variants in TPMT and NUDT15 in children with acute lymphoblastic leukemia.
1/2022	Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy.
1/2022	Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation.
11/2021	Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks.
10/2021	Individual prediction of nonadherence to oral mercaptopurine in children with acute lymphoblastic leukemia: Results from COG AALL03N1.
10/2021	Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase.
10/2021	Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical models.
1/2021	Association of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary V Relling Research Topics

Disease

116	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2002
43	Leukemia 01/2022 - 04/2002
33	Neoplasms (Cancer) 01/2021 - 04/2002
21	Osteonecrosis (Kienbock's Disease) 01/2022 - 10/2004
12	Hypersensitivity (Allergy) 01/2021 - 06/2009
11	Residual Neoplasm 01/2021 - 06/2002
5	Thrombosis (Thrombus) 01/2020 - 08/2003
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2021 - 08/2017
4	Overweight 01/2019 - 12/2006
4	Infections 01/2019 - 05/2007
3	Glucosephosphate Dehydrogenase Deficiency 01/2022 - 01/2019
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 07/2013
3	Cardiomyopathies (Cardiomyopathy) 01/2020 - 05/2012
3	Glucocorticoid Receptor Deficiency 01/2020 - 12/2008
3	Genetic Predisposition to Disease (Genetic Predisposition) 11/2019 - 01/2007
3	Pain (Aches) 09/2017 - 12/2011
3	Autoimmune Diseases (Autoimmune Disease) 08/2017 - 01/2012
2	Hypertriglyceridemia 01/2021 - 01/2020
2	Necrosis 01/2021 - 07/2013
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 02/2015
2	Immediate Hypersensitivity 05/2019 - 03/2015
2	Central Nervous System Diseases (CNS Diseases) 11/2018 - 03/2011
2	Disease Susceptibility (Diathesis) 04/2016 - 11/2006
2	Philadelphia Chromosome 09/2014 - 03/2011
2	Hypertension (High Blood Pressure) 03/2014 - 06/2008
2	Second Primary Neoplasms (Neoplasms, Second) 08/2003 - 05/2003
1	Hemolytic Anemia 01/2022

Drug/Important Bio-Agent (IBA)

25	Asparaginase (Elspar)FDA Link 01/2022 - 08/2004
25	Methotrexate (Mexate)FDA LinkGeneric 12/2020 - 07/2002
21	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2022 - 01/2002
21	Pharmaceutical PreparationsIBA 01/2022 - 06/2002
18	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 11/2004
14	GlucocorticoidsIBA 01/2020 - 05/2008
9	Thioguanine (Tioguanine)FDA Link 01/2019 - 06/2003
8	NucleotidesIBA 12/2020 - 06/2003
7	AntibodiesIBA 10/2019 - 02/2012
6	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 08/2004
6	Etoposide (VP 16)FDA LinkGeneric 11/2004 - 04/2002
5	Transcription Factors (Transcription Factor)IBA 11/2021 - 01/2004
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2006
5	Messenger RNA (mRNA)IBA 12/2020 - 08/2006
5	AnthracyclinesIBA 01/2020 - 06/2008
5	Cytochrome P-450 CYP3AIBA 06/2008 - 11/2002
4	EnzymesIBA 01/2022 - 09/2011
4	ChromatinIBA 01/2022 - 11/2019
4	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2005
4	pegaspargase (Oncaspar)FDA Link 01/2021 - 10/2019
4	Folic Acid (Vitamin M)FDA LinkGeneric 12/2020 - 10/2004
4	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 08/2004
4	Prednisone (Sone)FDA LinkGeneric 01/2019 - 01/2004
4	2-mercaptopurineIBA 01/2017 - 01/2002
4	SteroidsIBA 07/2013 - 05/2007
4	AntimetabolitesIBA 06/2008 - 11/2004
3	Dasatinib (BMS 354825)FDA Link 01/2022 - 03/2011
3	AntigensIBA 01/2021 - 01/2019
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2017
3	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2019 - 08/2004
3	Opioid Analgesics (Opioids)IBA 09/2017 - 12/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2017 - 06/2008
3	purineIBA 01/2016 - 09/2004
3	gamma-Glutamyl Hydrolase (Carboxypeptidase G2)IBA 08/2006 - 07/2002
3	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 01/2006 - 02/2005
3	Reduced Folate Carrier ProteinIBA 08/2005 - 08/2003
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 08/2014
2	venetoclaxIBA 01/2021 - 01/2020
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2021 - 05/2019
2	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2008
2	RNA (Ribonucleic Acid)IBA 01/2020 - 07/2015
2	Drug CombinationsIBA 01/2020 - 05/2003
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2020 - 01/2016
2	Immunoglobulin E (IgE)IBA 05/2019 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2019 - 03/2015
2	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2019 - 01/2019
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017 - 02/2011
2	AlbuminsIBA 01/2017 - 02/2011
2	CholesterolIBA 01/2017 - 02/2011
2	Biological ProductsIBA 01/2016 - 02/2012
2	Indicators and Reagents (Reagents)IBA 04/2015 - 06/2002
2	Phosphotransferases (Kinase)IBA 09/2014 - 03/2011
2	Alcohol OxidoreductasesIBA 05/2012 - 06/2008
2	CreatinineIBA 02/2012 - 06/2008
2	HomocysteineIBA 01/2012 - 08/2003
2	methotrexate polyglutamateIBA 05/2009 - 01/2005
2	Calcitriol Receptors (Calcitriol Receptor)IBA 05/2007 - 10/2004
2	catechol (pyrocatechol)IBA 01/2004 - 04/2002
1	Amino Acids FDA Link 01/2022
1	Zoledronic Acid (Zometa)FDA Link 10/2021
1	AsparagineIBA 10/2021
1	Diphosphonates (Bisphosphonates)IBA 10/2021
1	Fenofibrate (CiL)FDA LinkGeneric 01/2021
1	Excipients (Suspending Agents)IBA 01/2021
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2021

Therapy/Procedure

61	Therapeutics 01/2022 - 03/2002
17	Drug Therapy (Chemotherapy) 01/2022 - 08/2004
12	Remission Induction 01/2020 - 04/2003
3	Cranial Irradiation 12/2019 - 11/2004
2	Radiotherapy 06/2019 - 08/2003
2	Aftercare (After-Treatment) 03/2007 - 08/2004
1	Injections 01/2021